MCU and cancer: An example is the activity of mitochondrial transporters VDAC and MCU, which have been found to be responsible for aberrant metabolism that supports cancer progression and therapy resistance (Azoulay-Zohar et al., 2004; Abu-Hamad et al., 2008; Chakraborty et al., 2017).